>>> US Research Calls

Research Calls

  • Upgrades:
    • Diamondrock Hospitality (DRH) upgraded to Outperform from In-line at Evercore ISI
    • Enviva (EVA) upgraded to Strong Buy from Outperform at Raymond James; tgt $80
    • EOG Resources (EOG) upgraded to Buy from Neutral at Goldman; tgt raised to $143
    • GN Store Nord (GGNDF) upgraded to Outperform from Neutral at Credit Suisse
    • Jamf Holding (JAMF) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $28
    • Juniper Networks (JNPR) upgraded to Neutral from Underweight at Piper Sandler; tgt raised to $29
    • Owens Corning (OC) upgraded to Buy from Underperform at BofA Securities; tgt raised to $95
    • PotlatchDeltic (PCH) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $55
    • Target (TGT) upgraded to Buy from Hold at Jefferies; tgt raised to $185
    • Xylem (XYL) upgraded to Outperform from Market Perform at Cowen; tgt raised to $105
  • Downgrades:
    • ACM Research (ACMR) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $9
    • Carvana (CVNA) downgraded to Neutral from Outperform at Wedbush; tgt lowered to $15
    • Cleveland-Cliffs (CLF) downgraded to Underperform from Neutral at Exane BNP Paribas; tgt $14.30
    • Descartes (DSGX) downgraded to Underweight from Equal Weight at Barclays; tgt lowered to $60
    • Global Payments (GPN) downgraded to Neutral from Outperform at Exane BNP Paribas; tgt $115
    • Hayward Holdings (HAYW) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $8
    • Hewlett Packard Enterprise (HPE) downgraded to Neutral from Outperform at KGI Securities; tgt $13
    • Intel (INTC) downgraded to Underperform from Neutral at KGI Securities; tgt $13
    • Int'l Paper (IP) downgraded to Sell from Hold at Deutsche Bank; tgt lowered to $29
    • Masco (MAS) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $46
    • Mohawk (MHK) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $100
    • NGM Biopharmaceuticals (NGM) downgraded to Neutral from Buy at Goldman; tgt lowered to $4
    • NGM Biopharmaceuticals (NGM) downgraded to Outperform from Strong Buy at Raymond James; tgt lowered to $4
    • NXP Semi (NXPI) downgraded to Neutral from Outperform at KGI Securities; tgt $155
    • Packaging Corp (PKG) downgraded to Sell from Hold at Deutsche Bank; tgt lowered to $104
    • Pegasystems (PEGA) downgraded to Underweight from Equal Weight at Barclays; tgt lowered to $25
    • Palomar Holdings (PLMR) downgraded to Mkt Perform from Mkt Outperform at JMP Securities
    • PDC Energy (PDCE) downgraded to Neutral from Buy at Goldman; tgt $74
    • Resolute Forest Products (RFP) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt $23
    • RingCentral (RNG) downgraded to Neutral from Buy at BTIG Research
    • RPM Inc (RPM) downgraded to Neutral from Buy at UBS; tgt lowered to $101
    • Sunstone Hotel (SHO) downgraded to In-line from Outperform at Evercore ISI
    • Syneos Health (SYNH) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $53
    • WalkMe Ltd. (WKME) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $9
  • Others:
    • Abbott Labs (ABT) initiated with an Overweight at Barclays; tgt $118
    • Baxter (BAX) initiated with an Overweight at Barclays; tgt $64
    • Bentley Systems (BSY) initiated with a Buy at Rosenblatt; tgt $37
    • Boston Scientific (BSX) initiated with an Overweight at Barclays; tgt $49
    • Church & Dwight (CHD) initiated with an In-line at Evercore ISI
    • Clorox (CLX) initiated with an Underperform at Evercore ISI
    • Dexcom (DXCM) initiated with an Equal Weight at Barclays; tgt $103
    • Edwards Lifesciences (EW) initiated with an Overweight at Barclays; tgt $96
    • Esquire Financial (ESQ) initiated with an Outperform at Keefe Bruyette; tgt $53
    • Exelixis (EXEL) initiated with a Mkt Outperform at JMP Securities; tgt $26
    • Globus Medical (GMED) initiated with an Overweight at Barclays; tgt $69
    • Insulet (PODD) initiated with an Equal Weight at Barclays; tgt $238
    • Intuitive Surgical (ISRG) initiated with an Overweight at Barclays; tgt $235
    • Johnson & Johnson (JNJ) initiated with an Equal Weight at Barclays; tgt $175
    • Keros Therapeutics (KROS) initiated with a Buy at Truist; tgt $100
    • Kimberly-Clark (KMB) initiated with an In-line at Evercore ISI
    • Medtronic (MDT) initiated with an Equal Weight at Barclays; tgt $90
    • NuVasive (NUVA) initiated with an Overweight at Barclays; tgt $53
    • NVR (NVR) resumed with a Buy at BofA Securities; tgt $4900
    • PropTech Investment Corporation II (PTIC) initiated with a Buy at DA Davidson; tgt $12
    • Simon Properties (SPG) initiated with a Peer Perform at Wolfe Research
    • Stryker (SYK) initiated with an Overweight at Barclays; tgt $239
    • Tandem Diabetes Care (TNDM) initiated with an Overweight at Barclays; tgt $75
    • The Trade Desk (TTD) initiated with an Equal-Weight at Morgan Stanley; tgt $60
    • UiPath (PATH) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $15
    • Zimmer Biomet (ZBH) initiated with an Underweight at Barclays; tgt $104